ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['lenalidomide', ' lena', 'cilta-cel', 'cartitude-4', 'cartitude', 'multiple myeloma']
#asco23 simultaneous publication in for lba106: first phase 3 results from cartitude-4: cilta-cel versus standard of care (pvd or dpd) in lenalidomide-refractory multiple myeloma. view abstract: 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.